Connect with us

Business

Johnson & Johnson plans to have 100 million vaccines for Americans by spring, board member says – CNBC

A J&J board member said “if the clinical trial works out,” the company could significantly increase the nation’s Covid vaccine supply availability.

Published

on

post featured image

Johnson & Johnson board member Dr. Mark McClellan told CNBC that “if the clinical trial works out,” the company could significantly increase the nation’s Covid vaccine supply availability within the coming weeks. 
“I do know that J&J is making a very large supply, going all out with its production, both here in the U.S. and elsewhere around the world, with the goal of having perhaps enough vaccines for 100 million Americans by spring, by this April or so,” said the former FDA Commissioner in a Thursday…

Click here to view the original article.